Results of a phase II trial of olaparib in combination with ceralasertib in patients with recurrent and unresectable osteosarcoma.

Authors: Suzanne J. Forrest, J. Andrew Livingston, Kieuhoa Tran Vo, Julia Lynne Glade Bender, Amy Opara, Simon Smith, Neel Shah, Nan Chen, Wendy B London, E. Alejandro Sweet-Cordero, Katherine A. Janeway

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.10005

Source: Full article

---

Abstract

10005